Sudan I is a potential carcinogen for humans: Evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes

Cancer Research

Volumn 62, Issue 20, 2002, Pages 5678-5684

  Stiborová, Marie ^a   Martínek, Václav ^a   Rýdlová, Helena ^a   Hodek, Petr ^a   Frei, Eva ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CYTOCHROME P450 1A1; CYTOCHROME P450 INHIBITOR; PHOSPHORUS 32; SUDAN I;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; DETOXIFICATION; DNA ADDUCT; ENZYME INHIBITION; ENZYME PURIFICATION; HUMAN; HUMAN CELL; INSECT CELL; LIVER MICROSOME; METABOLISM; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RAT; SEQUENCE ANALYSIS; SWINE; WESTERN BLOTTING;

ANIMALS; BIOTRANSFORMATION; CARCINOGENS; CYTOCHROME P-450 CYP1A1; HUMANS; METABOLIC DETOXICATION, DRUG; MICROSOMES, LIVER; NAPHTHOLS; OXIDATION-REDUCTION; RABBITS; RATS; RECOMBINANT PROTEINS; SWINE; SWINE, MINIATURE;

EID: 0037108678     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Sudan I. IARC Monographs, Vol. 8, pp. 225-231. Lyon, France IARC, 1975.
2. Garner, R. C., Martin, C. N., and Clayson, D. B. Carcinogenic aromatic amines and related compounds. In: C. E., Searle, (ed.). Chemical Carcinogens. 3rd Ed., ACN Monograph 182., Vol. 1, pp. 175-302. Washington, DC.: American Chemical Society, 1984.
3. Westmoreland, C., and Gatehouse, D. G. The differential clastogenicity of Solvent Yellow 14 and FD & C Yellow No. 6 in vivo in the rodent micronucleus test (observation of species and tissues specificity). Carcinogenesis (Lond.), 12: 1403-1407, 1991.
4. NCI Carcinogenesis Bioassay of C. I. Solvent Yellow 14 in F344/N Rats and B6C3F1 Mice. Technical Report No. 226. Bethesda, MD: United States National Cancer Institute, 1982.
5. Moller, P., and Wallin, H., Genotoxic hazards of azo pigments and other colorants related to 1-phenylazo-2-hydroxynaphthalene. Mutat. Res., 462: 13-30, 2000.
6. Kozuka, T., Tashiro, M., Sano, S., Fujimoto, K., Nakamura, Y., Hashimoto, S., and Nakaminami, G. Pigmented contact dermatitis from azo dyes. I. Cross-sensitivity in humans. Contact Dermatitis, 6: 330-336, 1980.
7. Zeiger, E., Andersen, B., Haworth, S., Lawlor, T., and Mortelmans, K. Salmonella mutagenicity tests. IV. Results from the testing of 300 chemicals. Environ. Mutagen. 12(Suppl. 11): 1-158, 1988.
8. +/- assays. Mutat. Res., 189: 223-261, 1987.
9. Childs, J. J., and Clayson, D. S. The metabolism of 1-phenylazo-2-naphthol in the rabbit. Biochem. Pharmacol., 15: 1247-1258, 1966.
10. Stiborovä, M., Asfaw, B., Anzenbacher, P., Les̊etický L., and Hodek, P. The first identification of the benzenediazonium ion formation from a non-aminoazo dye, 1-phenylazo-2-hydroxynaphthalene (Sudan I) by microsomes of rat livers. Cancer Lett., 40: 319-326, 1988.
11. Stiborová, M., Asfaw, B., Anzenbacher, P., and Hodek, P., A new way to carcinogenicity of azo dye: The benzenediazonium ion formed from non-aminoazo dye, 1-phenylazo-2-hydroxynaphthalene (Sudan I) by microsomal enzymes binds to deoxyguanosine residues of DNA. Cancer Lett., 40: 327-333, 1988.
12. Stiborová, M., Asfaw, B., Frei, E., Schmeiser, H. H., and Wiessler, M. Benzenediazonium ion derived from Sudan I forms an 8-(phenylazo)guanine adduct. Chem. Res. Toxicol., 8: 489-498, 1995.
13. Stiborová, M., Asfaw, B., and Anzenbacher, P. Activation of carcinogens by peroxidase. Horseradish peroxidase-mediated formation of benzenediazonium ion from a non-aminoazo dye, 1-phenylazo-2-hydroxynaphthalene (Sudan I) and its binding to DNA. FEBS Lett., 232: 387-390, 1988.
14. 32P-postlabeling of DNA adducts derived from peroxidative activation of carcinogenic non-aminoazo dye 1-phenylazo-2-hydroxynaphthalene (Sudan I). Carcinogenesis (Lond.), 11: 1843-1848, 1990.
15. Stiborová, M., Schmeiser, H. H., and Frei, E. Prostaglandin H synthase mediated oxidation and binding to DNA of a detoxication metabolite of carcinogenic Sudan I 1-(phenylazo) 2, 6-dihydroxynaphthalene. Cancer Lett., 142: 53-60, 1999.
16. Guengerich, F. P. Comparisons of catalytic selectivity of cytochrome P450 subfamily members from different species. Chem. Biol. Interact., 106: 161-182, 1997.
17. Olah, G. A., Wu, A., Farooq, O., and Prakash, G. K. S. Olefins from crowded carbonyl compounds with tert-butyllithium (tert-butylmagnesium chloride)/thionyl chloride. Study of carbocationic reaction intermediates and rearrangement-cleavage under stable ion conditions using 13C NMR spectroscopy. J. Org. Chem., 55: 1792-1796, 1990.
18. Stiborová, M., Frei, E., Sopko, B., Wiessler, M., and Schmeiser, H. H. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy. Carcinogenesis (Lond.), 23: 617-625, 2002.
19. Gut, I., Nedelcheva, V., Soucek, P., Stopka, P., Vodicka, P., Gelboin, H. V., and Ingelman-Sundberg M. The role of CYP2EI and 2BI in metabolic activation of benzene derivatives. Arch. Toxicol., 71: 45-56, 1996.
20. Anzenbacher, P., Soucek, P., Anzenbacherová, E., Gut, I., Hrubý, K., Svoboda, Z., and Kvetina, J. Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples. Drug Metab. Dispos., 26: 56-59, 1998.
21. Wiechelman, K. J., Braun, R. D., and Fitzpatrick, J. D. Investigation of the bicinchoninic acid protein assay: Identification of the groups responsible for color formation. Anal. Biochem., 175: 231-237, 1988.
22. Omura, T., and Sato, R., The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem., 239: 2370-2378. 1964.
23. Guengerich, F. P., and Shimada, T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes. Chem. Res. Toxicol., 4: 391-407, 1991.
24. Guengerich, F. P., Wang, P., and Davidson, N. K. Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, ad humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochemistry, 21: 1698-1706, 1982.
25. Sonner, M., and Crestiel, T. Delayed ontogenesis of CYP1A2 in the human liver. Eur. J. Biochem., 251: 893-898, 1998.
26. Haugen, D. A., and Coon, M. J. Properties of electrophoretically homogeneous phenobarbital-inducible and beta-naphthoflavone-inducible forms of liver microsomal cytochrome P-450. J. Biol. Chem., 251: 7929-7939, 1976.
27. Yang, C. S., Tu, Y. Y., Koop, D. R., and Coon, M. J. Metabolism of nitrosamines by purified rabbit liver cytochrome P-450 isozymes. Cancer Res., 45: 1140-1145, 1985.
28. Borek-Dohalská, L., Hodek, P., Šulc, M., Stiborová, M. α-Naphthoflavone acts as activator and reversible or irreversible inhibitor of rabbit microsomal CYP3A6. Chem. Biol. Interact., 138: 85-106, 2001.
29. Saito, T., and Strobel, H. W. Purification to homogeneity and characterization of a form of cytochrome P-450 with high specificity for benzo[a] pyrene from β-naphthoflavone-pretreated rat liver microsomes. J. Biol. Chem., 256: 984-988, 1981.
30. Yasukochi, Y., Peterson, J. A., and Masters, B. NADPH-cytochrome c (P450) reductase: Spectrophotometric and stopped flow kinetic studies on the formation of reduced flavoprotein intermediates. J. Biol. Chem., 254: 7097-7104, 1979.
31. Strittmatter, P., Fleming, P., Connors, M., and Corcoran, D. Purification of cytochrome b5. Methods Enzymol., 52: 97-101, 1978.
32. Poison, A., von Wechmar, M. B., and van Regenmortel M. H. Isolation of viral IgY antibodies from yolks of immunized hens. Immmunol. Commun.. 9: 475-493. 1980.
33. Polson, A., von Wechmar, M. B., and Fazakerley, G. Antibodies to proteins from yolk of immunized hens. Immmunol. Commun., 9: 494-514, 1980.
34. Yamazaki, H., Shimada, T., Martin, M. V., and Guengerich, P. F. Stimulation of cytochrome P450 reactions by apo-cytochrome b5. Evidence against transfer of heme from cytochrome P450 3A4 to apo-cytochrome b5 or heme oxygenase. J. Biol. Chem., 276: 30885-30891, 2001.
35. Cleland, W. W. Statistical analysis of the enzyme kinetic data. Methods Enzymol., 63: 103-138. 1983.
36. Stiborová, M., Borek-Dohalská, L., Hodek, P., Mráz, J., and Frei, E. New selective inhibitors of cytochromes P450 2B and their application to antimutagenesis of tamoxifen. Arch. Biochem. Biophys., 403: 41-49, 2002.
37. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis (Lond.), 7: 1543-1551, 1986.
38. Murray, B. P., Edwards, R. J. Murray, S., Singleton, A. M., Davies, D. S., and Boobis, A. R. Human hepatic CYP1A1 and CYP1A2 content, determined determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhIP. Carcinogenesis (Lond.), 14: 585-592, 1993.
39. Edwards, R. J., Adams, D. A., Watts, P. S., Davies, D. S., and Boobis, A. R. Development of a comprehensive panel of antibodies against the major xenobiotic metabolising forms of cytochrome P450 in humans. Biochem. Pharmacol., 56: 377-387, 1998.
40. Brockmoller, J., Cascorbi, I., Henning, S., Meisel, C., and Roots, I. Molecular genetics of cancer susceptibility. Pharmacology (Basel), 61: 212-227, 2000.
41. Guengerich, F. P. Human cytochrome P450 enzymes. In: P. R. Ortiz de Montellano, (ed.). Cytochrome P450, pp. 473-535. New York: Plenum Press, 1995.
42. Drahushuk, A. T., McGarrigle, B. P., Larsen, K. E., Stegeman, J. J., and Olson, J. R. Detection of CYP1A1 protein in human liver and induction by TCDD in precision-cut liver slices incubated in dynamic organ culture. Carcinogenesis (Lond.), 19: 1361-1368, 1998.
43. Sy, S. K. B., Tang, B. K., Pastrakuljic, A., Roberts, E. A., and Kalow, W. Detailed characterization of experimentally derived human hepatic CYPIA1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamine. Eur. J. Clin. Pharmacol., 57: 377-386, 2001.
44. Shimada, T., Yun, C-H., Yamazaki, H., Gautier, J-C., Beaume, P. H., and Guengerich, F. P. Characterization of human lung microsomal cytochrome P-450 1A1 and its role in he oxidation f chemical carcinogens. Mol. Pharmacol., 41: 856-864, 1992.
45. Wheeler, C. W., Park, S. S., and Guenthner, T. M. Immunochemical analysis of a cytochrome P-4501A1 homologue in human lung microsomes. Mol. Pharmacol., 38: 634-643, 1990.
46. Jaiswal, A. K., Gonzalez, F. J., and Nebert, D. W. Human PI-450 gene sequence and correlation of mRNA with genetic differences in benzo[a]pyrene metabolism. Nucleic Acids Res., 12: 4503-4520, 1985.
47. Lubet, R. A., Connolly, G., Kouri, R. E., Nebert, D. W., and Bigelow, S. W. Biological effects of the Sudan dyes. Role of the Ah cytosolic receptor. Biochem. Pharmacol., 32: 3053-3058, 1983.